Skip to main content
Clinical Trials/NL-OMON23955
NL-OMON23955
Not yet recruiting
Not Applicable

Detection of paroxysmal atrial fibrillation using an automated Photo-plethysmography based artificial intelligence algorithm in ischemic stroke survivors

Bayer0 sites100 target enrollmentTBD
Conditionsischemic stroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ischemic stroke
Sponsor
Bayer
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Bayer

Eligibility Criteria

Inclusion Criteria

  • Adults, 18 years and above, cryptogenic stroke \< 3 months evaluated for a possible cardiac embolic source and not previously diagnosed with atrial fibrillation at the time of inclusion.
  • Cryptogenic stroke is defined as; 1\) an ischemic stroke or transient ischemic attack (TIA) that is not lacunar, 2\) absence of extracranial or intracranial atherosclerosis causing luminal stenosis, 3\) no definite source of cardioembolism and 4\) No other specific cause of stroke identified (e.g. arteritis, dissection, migraine/vasospasm, drug abuse)

Exclusion Criteria

  • haemorrhagic stroke, lacunar infarction, known atrial fibrillation, other known cause of the ischemic stroke, inability to use a smartphone and language barrier.

Outcomes

Primary Outcomes

Not specified

Similar Trials